edith a. perez, md: anti-her2 therapies
Published 11 years ago • 454 plays • Length 7:28Download video MP4
Download video MP3
Similar videos
-
8:11
her2 positive metastatic breast cancer advances
-
16:17
dr. edith perez discusses anti-her2 therapies -- 2012 sabcs
-
1:04
dr. edith perez discusses the adjuvant treatment of breast cancer
-
11:53
adjuvant treatment, her2 positive & targeted therapies
-
1:07
dr. edith perez discusses bolero-1 trial results for her2-positive breast cancer
-
1:06
dr. edith perez on the antibody-drug conjugate t-dm1
-
3:07
dr. edith perez on the development of targeted therapies
-
1:20
dr. edith perez on the etirinotecan pegol for her2-negative breast cancer
-
13:54
aacr 2011: bernard fisher, m.d.
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
19:39
research in focus: project innereye – assistive ai for cancer treatment
-
6:31
ah-ha moment leads to new breast cancer tumor testing standards - mayo clinic
-
4:26
altto trials findings for treating her2 breast cancer - mayo clinic
-
4:57
2010 sabcs interview with edith a. perez, m.d.
-
0:47
dr. edith perez on adjuvant treatments
-
6:47
how to select treatment for her2 breast cancer patients with brain metastasis?
-
1:15
dr. edith perez discusses adjuvant chemotherapy patient selection
-
1:14
dr. perez discusses t-dm1 and the marianne trial
-
1:25
dr. edith perez on immune checkpoint inhibition in triple-negative breast cancer
-
5:37
edith perez, md - panelist (introduction)
-
1:03
dr. edith perez describes the mayo clinic breast cancer translational genomics program
-
1:24
dr. perez discusses the bolero-2 everolimus trial